Scott L. Friedman

Scottlfriedman

Scott L. Friedman is an American physician and scientist known for his pioneering research in the field of liver disease, particularly hepatic fibrosis. He is a prominent figure in the study of stellate cells and their role in liver fibrosis.

Early Life and Education

Scott L. Friedman was born in New York City. He completed his undergraduate education at Rensselaer Polytechnic Institute and earned his medical degree from the Icahn School of Medicine at Mount Sinai. He completed his residency in internal medicine at the Beth Israel Deaconess Medical Center and a fellowship in gastroenterology at the University of California, San Francisco.

Career

Friedman began his career as a faculty member at the University of California, San Francisco, where he conducted groundbreaking research on hepatic stellate cells. He later joined the faculty at the Icahn School of Medicine at Mount Sinai, where he has held various leadership positions, including Chief of the Division of Liver Diseases.

Research Contributions

Friedman's research has significantly advanced the understanding of liver fibrosis. His work on hepatic stellate cells has elucidated their role in the development of fibrosis, leading to potential therapeutic targets for treating chronic liver diseases such as cirrhosis and non-alcoholic steatohepatitis (NASH).

Awards and Honors

Throughout his career, Friedman has received numerous awards and honors, including the American Association for the Study of Liver Diseases (AASLD) Distinguished Achievement Award and the International Liver Congress Recognition Award.

Personal Life

Friedman resides in New York City with his family. He is actively involved in various professional organizations and continues to contribute to the field of liver disease research.

See Also

• Liver disease
• Hepatic fibrosis
• Stellate cells
• Cirrhosis
• Non-alcoholic steatohepatitis